LUPANINE

SynDRA canonical compound SYN0010782 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	INS
Mechanism of action	insulin secretagogue \| sodium channel blocker \| sodium channel blocker, insulin secretagogue
Indication	diabetes mellitus
Disease area	Endocrinology

All known targets

Lupanin
(+)-Lupanine
d-Lupanine
2-Oxosparteine
(+)-2-Oxosparteine
Spartein-2-one
CHEBI:28193
RefChem:41753
DTXCID401508215
Lupanine d-form
Lupanine, (+/-)-
9K48888N9P
UNII-183KU7535A
UNII-9K48888N9P
Lupanine, D-
DL-LUPANINE
(+/-)-LUPANINE
LUPANINE, (+)-
(RAC)-2-OXOSPARTEINE
LUPANINE D-FORM [MI]
SCHEMBL564463
LUPANINE DL-FORM [MI]
orb1685045
(+/-)-2-OXOSPARTEINE
TMA0805
JYIJIIVLEOETIQ-XDQVBPFNSA-N
HY-N3359
AKOS040760061
AT20203
FL65068
DA-49111
CS-0023989
NS00094225
AE-508/21133018
(+)-2-oxosparteine
(7alpha,7aalpha,14alpha,14abeta)-dodecahydro-7,14-methano-2H,11H-dipyridol[1,2-a:1',2'-e][1,5]diazocin-11-one
2-oxosparteine
d-lupanine